ID: ALA3357965

Max Phase: Preclinical

Molecular Formula: C45H49N9O6

Molecular Weight: 811.94

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  N#CCNC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccc(Cn2nnc3c2-c2ccccc2CN(C(=O)CCCC(=O)NCCOCCOCCN)c2ccccc2-3)cc1

Standard InChI:  InChI=1S/C45H49N9O6/c46-21-23-49-45(58)38(29-32-9-2-1-3-10-32)50-44(57)34-19-17-33(18-20-34)30-54-43-36-12-5-4-11-35(36)31-53(39-14-7-6-13-37(39)42(43)51-52-54)41(56)16-8-15-40(55)48-24-26-60-28-27-59-25-22-47/h1-7,9-14,17-20,38H,8,15-16,22-31,47H2,(H,48,55)(H,49,58)(H,50,57)/t38-/m0/s1

Standard InChI Key:  DUAGYIZWZBIOEE-LHEWISCISA-N

Associated Targets(non-human)

Papain 844 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 811.94Molecular Weight (Monoisotopic): 811.3806AlogP: 3.77#Rotatable Bonds: 20
Polar Surface Area: 206.59Molecular Species: BASEHBA: 11HBD: 4
#RO5 Violations: 2HBA (Lipinski): 15HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.81CX Basic pKa: 9.44CX LogP: 2.72CX LogD: 0.72
Aromatic Rings: 5Heavy Atoms: 60QED Weighted: 0.07Np Likeness Score: -1.05

References

1. Wammes AE, Hendriks TG, Amatdjais-Groenen HI, Wijdeven MA, van Hest JC, van Delft FL, Ritschel T, Rutjes FP..  (2014)  Influence of azide incorporation on binding affinity by small papain inhibitors.,  22  (20): [PMID:24972724] [10.1016/j.bmc.2014.06.001]

Source